17 December 2020

Outbreaks Associated with Contaminated Antiseptics and Disinfectants

The Centers for Disease Control and Prevention (CDC) has estimated that health care-associated infections account for an estimated 1.7 million infections, 99,000 deaths, and $4.5 billion in excess health care costs annually (16). The key interventions used to control health care-associated infections include surveillance (27, 33), isolation of patients with communicable diseases (26) or multidrug-resistant pathogens (81), proper skin antisepsis prior to invasive procedures and hand hygiene by health care workers (12), and appropriate disinfection and sterilization of medical devices and environmental surfaces (73, 75, 79).
Multiple nosocomial outbreaks have resulted from inadequate antisepsis or disinfection. Inadequate skin antisepsis may result from a lack of intrinsic antimicrobial activity of the antiseptic, a resistant pathogen, overdilution of the antiseptic, or the use of a contaminated antiseptic. The inadequate disinfection of medical devices or environmental surfaces may result from a lack of intrinsic antimicrobial activity of the disinfectant, an incorrect choice of a disinfectant, a resistant pathogen, overdilution of the disinfectant, an inadequate duration of disinfection, a lack of contact between the disinfectant and the microbes, or the use of a contaminated disinfectant. Editorials have noted that contaminated antiseptics and disinfectants have been the occasional vehicles of hospital infections for more than 50 years (20, 72, 76). This paper concisely reviews nosocomial outbreaks associated with the use of a microbiologically contaminated germicide and focuses on the currently recommended germicides.


A precise understanding of terminology is important to understanding the uses of germicides in modern health care. Germicides are biocidal agents that inactivate microorganisms and include antiseptics, disinfectants, and preservatives. Antiseptics are antimicrobial substances that are applied to the skin or mucous membranes to reduce the microbial flora. Disinfectants are substances that are applied to inanimate objects to destroy harmful microorganisms, although they may not kill bacterial spores. Decontamination is a procedure that removes pathogenic microorganisms from objects so they are safe to handle, use, or discard. Finally, preservatives are incorporated into medications or fluids to prevent microbial growth. Germicides may become contaminated as a result of improper manufacturing techniques or during shipping (intrinsic contamination) or during manipulation or use within the health care facility (extrinsic contamination).
Disinfectants are further categorized by their degree of effectiveness (73, 75). The choice of disinfectant agent is based on the intended use of the patient care item (Table 1).


Microbial resistance to germicides has been reviewed previously (37, 49, 62, 68, 71). As with antibiotic resistance, resistance to germicides may be an intrinsic property or may arise either by chromosomal gene mutation or by the acquisition of genetic material in the form of plasmids or transposons (49, 68, 71). Importantly, although microbes may display intrinsic resistance to specific antiseptics, antibiotic-resistant pathogens (e.g., methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci) do not demonstrate resistance to germicides at the currently used contact times and concentrations (29, 66, 67, 69, 70, 92).


Antiseptics are used in health care to reduce the transient microbial flora on the hands of health care providers, to reduce the person-to-person transmission of microbes (e.g., methicillin-resistant Staphylococcus aureus), to prepare the skin of patients prior to invasive procedures, and to achieve surgical hand antisepsis. The products commonly used in the United States include alcohols, chlorhexidine, chloroxylenol, iodine and iodophors, quaternary ammonium compounds (e.g., benzethonium chloride), and triclosan (12). The antimicrobial spectra of the currently used antiseptics are displayed in Table 2. More than 40 outbreaks and pseudo-outbreaks due to contaminated antiseptics have been reported (Table 3) (4, 5, 8, 10, 11, 13-15, 17, 19, 20, 24, 25, 28, 30, 32, 34, 36, 38, 39, 43, 45-47, 50, 52-54, 58, 59, 61, 63, 78, 83-86, 89-91, 93).


The majority of alcohol-based hand antiseptics contain isopropanol, ethanol, or N-propanol. The latter agent, N-propanol, is not currently approved for use for hand hygiene in the United States. Antiseptic agents are available that combine two alcohols or alcohol solutions and another agent (e.g., hexachlorophene, quaternary ammonium compounds, povidone-iodine, triclosan, or chlorhexidine gluconate). Waterless alcohol foams, liquids, and gels are now widely used in health care to improve compliance with hand hygiene (35, 60, 65). Importantly, alcohols have poor activity against bacterial spores, protozoan oocysts, and certain nonlipophilic (nonenveloped) viruses.
The contamination of alcohol-based solutions has rarely been reported. One pseudoepidemic of bacteremia (34) and one outbreak of bacteremia (54) have been traced to contaminated alcohol used for skin antisepsis. These were traced to the use of intrinsically contaminated alcohol (34) and dilution of the alcohol with contaminated water (54).


Chlorhexidine gluconate is widely used in the United States for hand hygiene. Its antimicrobial activity occurs more slowly than that of alcohols.
Multiple outbreaks have been linked to contaminated chlorhexidine. Most reports have been traced to the use of contaminated water to prepare diluted preparations and/or the practice of reusing bottles to dispense chlorhexidine without adequate disinfection. Although most outbreaks have occurred with solutions containing less than 2% chlorhexidine, an outbreak has been reported with solutions of 2% to 4% chlorhexidine (90). The inappropriate use of chlorhexidine as a disinfectant has also led to outbreaks. Examples include the use of contaminated chlorhexidine solutions to disinfect glass reservoirs containing urinary bladder irrigants (51), plastic clamps (48), and thermometers (17). Outbreaks due to contaminated chlorhexidine/cetrimide solutions have also been reported (8, 13, 93).


Chloroxylenol, also known as parachlorometaxylenol, is a halogen-substituted phenolic compound that has been used both as a preservative and as an active agent in antimicrobial soaps. An outbreak of Serratia marcescens infection or colonization in a neonatal intensive care unit was traced to extrinsically contaminated 1% chloroxylenol soap (5).

Quaternary ammonium compounds.

Quaternary ammonium compounds are composed of a nitrogen atom linked directly to four alkyl groups, which may vary in their structure and complexity. Of this large group of compounds, alkyl benzalkonium chlorides are the most widely used as antiseptics. Other agents include benzethonium chloride, cetrimide, and cetylpyridium chloride. The FDA classifies benzalkonium chloride as having insufficient data to classify it as safe and effective for use for antiseptic hygiene.
More outbreaks have been ascribed to contaminated benzalkonium chloride than any other antiseptic (Table 3). In 2003, Tiwari and colleagues reviewed the literature and referenced multiple reports of outbreaks or pseudo-outbreaks associated with the use of benzalkonium chloride (86). The most common species were aerobic, gram-negative bacilli, including Burkholderia cepacia, S. marcescens, and Enterobacter spp. Most but not all outbreaks were linked to the storage of benzalkonium chloride with cotton or gauze or the improper dilution of the benzalkonium chloride solution. The use of benzalkonium chloride to disinfect endoscopes has also led to urinary tract and pulmonary infections (20), and the use of contaminated spray bottles for environmental disinfection led to S. marcescens infections complicating cardiopulmonary surgery (22). The failure of benzalkonium chloride as a preservative in multidose albuterol bottles led to respiratory tract colonization and infection (31). Contaminated benzalkonium chloride used to disinfect the septa of multidose corticosteroid bottles has led to injection site abscesses with Pseudomonas aeruginosa (56).

Iodine and iodophors.

Iodine has been used as an antiseptic for more than 100 years. Because iodine often causes irritation and discoloring of the skin, iodophors have largely replaced iodine as the active agent in antiseptics. Multiple outbreaks due to contaminated iodophors have been reported (Table 3). The prolonged survival of B. cepacia in commercially manufactured providone-iodine has been documented (3), and intrinsic contamination of a povidone-iodine solution led to both infections and pseudoinfections (10, 14, 36, 58-59). These reports of intrinsic microbial contamination of antiseptic formulations of povidone-iodine and poloxamer-iodine caused a reappraisal of the chemistry and use of iodophors. It was found that “free” iodine (I2) contributes to the bactericidal activity of iodophors and that dilutions of iodophors demonstrate more rapid bactericidal action than a full-strength povidone-iodine solution. The reason for the observation that dilution increases bactericidal activity is unclear, but it has been suggested that dilution of povidone-iodine results in a weakening of the iodine linkage to the carrier polymer, with an accompanying increase of free iodine in solution. Therefore, iodophors must be diluted according to the manufacturers' directions to achieve antimicrobial activity.
Although most reports of contaminated iodophors have reported contamination with gram-negative bacilli, O'Rourke and colleagues isolated Staphylococcus aureus from the rims of two bottles containing an iodophor in an operating room (57). No infections were noted as a result of this contamination.


Triclosan at concentrations of 0.2% to 2% has antimicrobial activity and has been incorporated into soaps for use by health care workers and into a variety of commercial products. It has a broad range of antimicrobial activity, but it is often bacteriostatic.
Liquid soap bottles containing 1% triclosan used as an operating room scrub were found to be contaminated with S. marcescens or Candida parapsilosis (7). However, no infections were reported. An outbreak of newborn conjunctivitis due to S. marcescens was associated with the use of intrinsically contaminated 0.5% triclosan antiseptic soap (50).


A variety of chemical agents are used as disinfectants; the choice of an agent depends on its intended use (Table 1). Disinfectants have not been as commonly involved in outbreaks as antiseptics (Table 4) (6, 9, 18, 20-23, 41, 42, 44, 55, 56, 64, 80, 82, 87, 88). The agents currently approved for use as high-level disinfectants (e.g., chlorine, peracetic acid, and ortho-phthalaldehyde) have rarely, if ever, been implicated in outbreaks. However, outbreaks may occur when ineffective disinfectants, including iodophors, alcohols, and overdiluted glutaraldehyde, are used for high-level disinfection.


Alcohol is widely used for the environmental disinfection of small areas (i.e., “spot” disinfection). Flammability precludes its use on large surfaces. Multiple outbreaks have resulted from the use of alcohols as “high-level” disinfectants for semicritical medical devices. Rarely, contaminated alcohol used as a surface disinfectant has been linked to outbreaks. For example, Berger reported an epidemic of pseudobacteremia with Bacillus cereus that was traced to contaminated cotton pads maintained in 70 to 90% ethanol that were used to disinfect the top of blood culture bottles before inoculation (9). Alcohol is not effective as a surface disinfectant against adenovirus, and its use to disinfect tonometer tips has been associated with epidemic keratoconjunctivitis (40).


The biocidal activity of glutaraldehyde is a consequence of its alkylation of the sulfydryl, hydroxy, carboxyl, and amino groups of microorganisms, which alters RNA, DNA, and protein synthesis. There have been reports of microorganisms with resistance to glutaraldehyde, including some mycobacteria (e.g., Mycobacterium chelonae and Mycobacterium xenopi), Methylobacterium mesephilicum, Trichosporon, fungal ascospores, and Cryptosporidium (73). A pseudo-outbreak caused by Mycobacterium chelonae and Methylobacterium mesophilicum due to contamination of an automated endoscope washer was reported (41). M. chelonae grew from the endoscopes, the automated washers, and the glutaraldehyde from the washers.

Quaternary ammonium compounds.

The bactericidal action of the quaternary ammonium compounds has been attributed to the inactivation of energy-producing enzymes, denaturation of essential cell proteins, and disruption of the cell membrane. A pseudo-outbreak of B. cepacia bacteremia was traced to the use of a contaminated quaternary ammonium compound to disinfect the rubber stoppers of blood culture bottles (21).


Formaldehyde inactivates microorganisms by alkylating the amino and sulfhydryl groups of proteins and the ring nitrogen atoms of purine bases. The aqueous solution is virucidal, bactericidal, tuberculocidal, fungicidal, and sporicidal. An outbreak of Klebsiella oxytoca sepsis in a neonatal and pediatric intensive care unit was traced to a contaminated solution of formaldehyde (8.0 g/dl) used for disinfection of surfaces and infusion pumps (64), while an outbreak of Pseudomonas sepsis due to deficient formaldehyde mixing used to disinfect dialyzers was reported (88).


The contamination of phenolics used for disinfection has been reported previously (Table 4).


Outbreaks and pseudo-outbreaks related to contaminated germicides have most commonly been reported with contaminated antiseptics. Outbreaks from contaminated high-level disinfectants have rarely, if ever, been reported. Outbreaks from contaminated intermediate- and low-level disinfectants have occasionally been reported. All outbreaks associated with contaminated germicides have occurred due to gram-negative bacilli or mycobacteria. This is felt to be due to the fact that the outer membrane of gram-negative bacteria or the complex cell wall of mycobacteria acts as a barrier to germicides (49).
Both outbreaks and sporadic failures of germicides may be due to user error rather than microbial contamination. Common errors include the use of overdiluted solutions, the use of outdated products, the use of tap water to dilute the germicide, the refilling of small-volume dispensers from large-volume stock containers, and the improper selection of an appropriate product (e.g., the use of a low-level disinfectant rather than a high-level disinfectant to disinfect an endoscope). Because multiple outbreaks have resulted from the refilling of small-volume dispensers from large-volume stock containers, small-volume containers should be used until they are completely empty (i.e., do not “top off” the containers), rinsed with tap water, and then air dried before they are refilled. When a potential failure of proper disinfection or sterilization occurs, we recommend the use of a standardized risk assessment for determining patient risk and the need to inform patients (74).
A critical component of disinfection is prior cleaning. Prior cleaning is necessary to remove proteinaceous material and biofilms to allow the germicide to achieve adequate microbial inactivation. Experimental studies have demonstrated that the physical thickness of the cellular and extracellular material that forms on surfaces (i.e., biofilms) can protect imbedded organisms from the microbicidal actions of disinfectants and antiseptics (1, 2). For example, the bacteria growing in a biofilm can be up to 1,500 times more resistant to germicides than the same bacteria growing in liquid culture (77). The failure to properly clean medical devices may lead to inadequate microbial inactivation for all chemical germicides.
With the use of more effective agents and newer guidelines, the number of outbreaks due to contaminated germicides had decreased over the past 50 years. However, in order to prevent future outbreaks associated with contaminated germicides, it is critical to follow the standard recommendations, which are as follows: (i) use only CDC-recommended and FDA-cleared antiseptics; (ii) use only CDC-recommended and EPA-registered or FDA-cleared disinfectants; (iii) use all germicides at their recommended use dilution, and do not overdilute products; (iv) use sterile water to dilute antiseptics; (v) use all germicides for the recommended contact times; (vi) do not use germicides labeled only as antiseptics for the disinfection of medical devices or surface disinfection; (vii) follow the recommended procedures in the preparation of products to prevent extrinsic contamination; (viii) small-volume dispensers that are refilled from large-volume stock containers should be used until they are entirely empty, and then they should be rinsed with tap water and air dried before they are refilled; and (ix) store stock solutions of germicides as indicated on the product label.
TABLE 1. Classification and uses of chemical disinfectantsa
Disinfection processLevel of microbial inactivationAgentsHealth care uses
High-level (liquid immersion)Destroys all microorganisms except high numbers of bacterial spores>2% glutaraldehyde (20-45 min), 0.55% ortho-phthalaldehyde (12 min), 1.12% glutaraldehyde and 1.93% phenol (20 min), 7.35% hydrogen peroxide and 0.23% peracetic acid (15 min), 7.5% hydrogen peroxide (30 min), 1.0% hydrogen peroxide and 0.08% peracetic acid (25 min), and 650-675 ppm chlorine (10 min)Heat-sensitive semicritical patient care items (gastrointestinal endoscopes and bronchoscopes, tonometers, vaginal specula)
Intermediate-level (liquid contact)Destroys vegetative bacteria, mycobacteria, most viruses, and most fungi but not bacterial sporesEPA-registered hospital disinfectants with label claiming tuberculocidal activity, such as chlorine-based products and phenolics (≥60 s)Noncritical patient care items (blood pressure cuffs) or surfaces (bed rails) with visible blood
Low-level (liquid contact)Destroys vegetative bacteria and some fungi and viruses but not mycobacteria or sporesEPA-registered hospital disinfectants with no tuberculocidal claim, such as chlorine-based products, phenolics, and quarternary ammonium compounds (≥60 s), or 70%-90% alcoholNoncritical patient care items (blood pressure cuffs) or surfaces (bed rails) with no visible blood
Data are from reference 75.
TABLE 2. Antimicrobial spectrum and characteristics of hand hygiene antiseptic agentsa
GroupActivity againstb:    Speed of actionComments
 Gram-positive bacteriaGram-negative bacteriaMycobacteriaFungiViruses  
Alcohols+++++++++++++++FastOptimum concentration, 60%-95%; no persistent activity
Chlorhexidine (2% and 4% aqueous)++++++++++IntermediatePersistent activity; rare allergic reactions
Iodine compounds++++++++++++++IntermediateCauses skin burns; usually too irritating for hand hygiene
Iodophors+++++++++++IntermediateLess irritating than iodine; acceptance varies
Phenol derivatives+++++++IntermediateActivity neutralized by nonionic surfactants
Triclosan+++++++++IntermediateAcceptability on hands varies
Quaternary ammonium compounds++++SlowUsed only in combination with alcohols; ecologic concerns
Data are from reference 12. Information for hexachlorophene is not included because it is no longer an accepted ingredient of hand disinfectants.
+++, excellent; ++, good but does not include entire microbial spectrum; +, fair; −, no activity or not sufficient.
TABLE 3. Outbreaks and pseudo-outbreaks due to contaminated antiseptics
AntisepticContaminant(s)Site(s) of microbesMechanism of contamination/sourceAuthor(s), yr (reference)
AlcoholsBacillus cereusBlood (pseudobacteremia), pleural fluidIntrinsic contaminationHsueh et al., 1999 (34)
AlcoholsBurkholderia cepaciaBlood (catheter related)Contaminated tap water used to dilute alcohol for skin antisepsisNasser et al., 2004 (54)
ChlorhexidinePseudomonas spp.Not statedRefilling contaminated bottles; washing used bottles using cold tap water; contaminated washing apparatus; low concentration (0.05%)Burdon and Whitby, 1967 (13)
ChlorhexidineBurkholderia cepaciaBlood, urinary, woundsNot determinedSpeller et al., 1971 (84)
ChlorhexidineFlavobacterium meningosepticumBlood, CSF,a wounds, skinNot determined but possibly due to contaminated water and/or topping off of stock solution or low concentration (1:1,000-1:5,000)Coyle-Gilchrist et al., 1976 (17)
ChlorhexidinePseudomonas sp., Serratia marcescens, Flavobacterium sp.Not statedNot determined, but authors speculate due to overdilution or refilling of contaminated bottlesMarrie and Costerton, 1981 (47)
ChlorhexidinePseudomonas aeruginosaWoundsTap water used to dilute stock solutions; low concentration (0.05%)Anyiwo et al., 1982 (4)
ChlorhexidineBulkholderia cepaciaBlood, wounds, urine, mouth, vaginaMetal pipe and rubber tubing in pharmacy through which deionized water passed during dilution of chlorhexidine; low concentrationSobel et al., 1982 (83)
ChlorhexidineRalstonia pickettiiBloodContaminated bidistilled water used to dilute chlorhexidine; low concentration (0.05%)Kahan et al., 1983 (38)
ChlorhexidineRalstonia pickettiiBloodContaminated deionized water; low concentration (0.05%)Poty et al., 1987 (63)
ChlorhexidineRalstonia pickettiiBlood (pseudobacteremia)Distilled water used to dilute chlorhexidine; low concentration (0.05%)Verschraegen et al., 1985 (89)
ChlorhexidineRalstonia pickettiiBlood (pseudobacteremia)Distilled water used to dilute chlorhexidine; low concentration (0.05%)Maroye et al., 2000 (46)
ChlorhexidineAchromobacter xylosoxidansBlood, woundsAtomizer (low concentration, 600 mg/liter)Vu-Thien et al., 1998 (91)
ChlorhexidineAchromobacter xylosoxidansBloodAtomizerTena et al., 2005 (85)
ChlorhexidineSerratia marcescensBood, urine, wounds, sputum, othersNot determined, but use of nonsterile water for dilution to 2% and distribution in reusable nonsterile containersVigeant et al., 1998 (90)
Chlorhexidine plus cetrimidePseudomonas multivoransWoundsTap water used to prepare stock solutions; low concentrations (0.05% chlorhexidine and 0.5% cetrimide)Bassett, 1970 (8)
Chlorhexidine plus cetrimideStenotrophomonas maltophiliaUrine, umbilical swabs, catheter tips, othersDeionized water used to prepare solutions; failure to disinfect contaminated bottles between useWishart and Riley, 1976 (93)
ChloroxylenolSerratia marcescensMultiple sitesContaminated (extrinsic) 1% chloroxylenol soap; sinkArchibald et al., 1997 (5)
Benzalkonium chloridePseudomonas speciesBloodStorage of benzalkonium chloride (0.1%) with cotton/gauzePlotkin and Austrian, 1958 (61)
Benzalkonium chloridePseudomonas-Achromobacteriaceae groupBlood, urineStorage of benzalkonium chloride (0.1%) with cotton/gauze; dilution with nonsterile waterLee and Fialkow, 1961 (43)
Benzalkonium chlorideEnterobacter aerogenesBlood, sinus tractStorage of benzalkonium chloride (0.13%) with cotton/gauzeMalizia et al., 1960 (45)
Benzalkonium chloridePseudomonas kingiiUrineContamination (intrinsic) of antisepticCDC, 1969 (15)
Benzalkonium chloridePseudomonas EO-1UrineContaminated (intrinsic) cleansing-germicide solutionHardy et al., 1970 (32)
Benzethonium chloridePseudomonas speciesBlood (pseudobacteremia)Contaminated (intrinsic solution; 0.2%)Dixon et al., 1976 (20)
Benzalkonium chlorideBulkholderia cepacia, Enterobacter speciesBlood (pseudobacteremia)Storage of benzalkonium chloride with cotton/gauze; improper dilution; storage bottles infrequently sterilizedKaslow et al., 1976 (39)
Benzalkonium chlorideBulkholderia cepaciaBacteremiaStorage of benzalkonium chloride with rayon balls; failure to disinfect squeeze bottlesFrank and Schaffner, 1976 (25)
Benzalkonium chlorideSerratia marcescensIntravenous catheters (dogs and cats), other sitesStorage of benzalkonium chloride (0.025%) with cotton/gauzeFox et al., 1981 (24)
Benzalkonium chlorideSerratia marcescensJointStorage of benzalkonium chloride with cotton/gauzeNakashima et al., 1987 (53)
Benzalkonium chlorideSerratia marcescensCSFContamination (extrinsic) of stock bottleSautter et al., 1984 (78)
Benzalkonium chlorideMycobacterium chelonaeSkin abscessesStorage of benzalkonium chloride with cotton/gauze; improper dilutionGeorgia Division of Public Health, 1990 (28)
Benzalkonium chlorideMycobacterium abscessusJointStorage of benzalkonium chloride with cotton/gauze; dilution with probable contaminated tap waterTiwari et al., 2003 (86)
Benzalkonium chloride/ picloxydineBurkholderia cepaciaBlood, urine, wound, sputumWater used to dilute the antisepticGuinness and Levey, 1976 (30)
Benzalkonium chloride/ picloxydineBurkholderia cepaciaBloodWater used to dilute the antisepticMorris et al., 1976 (52)
Povidone-iodineBurkholderia cepaciaBlood (pseudobacteremia)Intrinsic contamination 10% povidone-iodine (probable B. cepacia proliferating on the deionizing resin in the water system)Berkelman et al., 1981 (10)
Povidone-iodineBurkholderia cepaciaBlood (pseudobacteremia)Intrinsic contaminationCraven et al., 1981 (19)
Poloxamer-iodinePseudomonas aeruginosaPeritoneal fluid, woundIntrinsic contaminationParrott et al., 1982 (59)
Povidone-iodineBurkholderia cepaciaBlood (pseudobacteremia), peritoneal fluidIntrinsic contaminationCDC, 1989 (14); Jarvis, 1991 (36); Panlilio et al., 1992 (58)
Povidone-iodinePseudomonas putidaBlood, catheter tipsNot determinedBouallègue et al., 2004 (11)
TriclosanSerratia marcescensConjunctivaIntrinsic contaminationMcNaughton et al., 1995 (50)
CSF, cerebrospinal fluid.
TABLE 4. Reports of contaminated disinfectants
DisinfectantContaminating microbes (reference)
EthanolBacillus cereus (9)a
GlutaraldehydeMycobacterium chelonae (41),aMethylobacterium mesophilicum (41),aMycobacterium species (42, 87)
FormaldehydePseudomonas aeruginosa (88),aStenotrophomonas maltophilia (88), Klebsiella oxytoca (64)a
Quaternary ammonium compoundsBurkholderia cepacia (20, 21),aSerratia marcescens (22),aAchromobacter xylosoxydans (44),aPseudomonas aeruginosa (56, 80)a
PhenolicsPseudomonas species (18, 23, 55), Pseudomonas aeruginosa (6, a55), Alcaligenes faecalis (82)
Outbreak or pseudo-outbreak.


Anderson, R. L., B. W. Holland, J. K. Carr, W. W. Bond, and M. S. Favero.1990. Effect of disinfectants on pseudomonads colonized on the interior surface of PVC pipes. Am. J. Public Health80:17-21.
Anderson, R. L., R. W. Vess, J. H. Carr, W. W. Bond, A. L. Panlilio, and M. S. Favero.1991. Investigations of intrinsic Pseudomonas cepacia contamination in commercially manufactured povidone-iodine. Infect. Control Hosp. Epidemiol.12:297-302.
Anderson, R. L., R. W. Vess, A. L. Panlilio, and M. S. Favero.1990. Prolonged survival of Pseudomonas cepacia in commercially manufactured povidone-iodine. Appl. Environ Microbiol.56:3598-3600.
Anyiwo, C. E., A. O. Coker, and S. O. Daniel.1982. Pseudomonas aeruginosa in postoperative wounds from chlorhexidine solutions. J. Hosp. Infect.3:189-191.
Archibald, L. K., A. Corl, B. Shah, M. Schulte, M. J. Arduino, S. Aguero, D. J. Fisher, B. W. Stechenberg, S. N. Banerjee, and W. R. Jarvis.1997. Serratia marcescens outbreak associated with extrinsic contamination of 1% chlorxylenol soap. Infect. Control Hosp. Epidemiol.18:704-709.
Baird, R., and R. A. Shooter.1976. Pseudomonas aeruginosa infections associated with use of contaminated medicaments. Br. Med. J.ii:349-350.
Barry, M. A., D. E. Craven, T. A. Goularte, and D. A. Lichtenberg.1984. Serratia marcescens contamination of antiseptic soap containing triclosan: implications for nosocomial infections. Infect. Control5:427-430.
Bassett, D. C. J.1970. Wound infection with Pseudomonas multivorans: a water-borne contaminant of disinfection solutions. Lanceti:1188-1191.
Berger, S. A.1983. Pseudobacteremia due to contaminated alcohol swabs. J. Clin. Microbiol.18:974-975.
Berkelman, R. L., S. Lewin, J. R. Allen, R. L. Anderson, L. D. Budnick, S. Shapiro, S. M. Friedman, P. Nicholas, R. S. Holzman, and R. W. Haley.1981. Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann. Intern. Med.95:32-36.
Bouallègue, O., R. Mzoughi, F. X. Weill, N. Mahdhaoui, Y. Ben Salem, H. Sboui, F. Grimont, and P. A. Grimont.2004. Outbreak of Pseudomonas putida bacteraemia in a neonatal intensive care unit. J. Hosp. Infect.57:88-91.
Boyce, J. M., and D. Pittet.2002. Guidelines for hand hygiene in health-care settings. Morb. Mortal. Wkly. Rep.51(RR-16):1-45.
Burdon, D. W., and J. L. Whitby.1967. Contamination of hospital disinfectants with Pseudomonas species. Br. Med. J.11:153-155.
Centers for Disease Control and Prevention.1989. Contaminated providone-iodine solution—Texas. Morb. Mortal. Wkly. Rep.38:133-134.
Centers for Disease Control and Prevention.1969. Food and Drug Administration warning—contaminated detergent solution. Morb. Mortal. Wkly. Rep.18:366.
Centers for Disease Control and Prevention. October 2007, accession date. Healthcare-associated infections. Centers for Disease Control and Prevention, Atlanta, GA.
Coyle-Gilchrist, M. M., P. Crewe, and G. Roberts.1976. Flavobacterium meningosepticum in the hospital environment. J. Clin. Pathol.29:824-826.
Cragg, J., and A. V. Andrews.1969. Bacterial contamination of a disinfectant. Br. Med. J.iii:57.
Craven, D. E., B. Moody, M. G. Connolly, N. R. Kollisch, K. D. Stottmeier, and W. R. McCabe.1981. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N. Engl. J. Med.305:621-623.
Dixon, R. E., R. A. Kaslow, D. C. Mackel, C. C. Fulkerson, and G. F. Mallison.1976. Aqueous quaternary ammonium antiseptics and disinfectants. JAMA236:2415-2417.
Ebner, W., E. Meyer, C. Schulz-Huotari, R. Scholz, G. Zilow, and F. D. Daschner.2005. Pseudocontamination of blood components with Burkholderia cepacia during quality controls. Transfusion Med.15:241-242.
Ehrenkranz, N. J., E. A. Bolyard, M. Wiener, and T. J. Cleary.1980. Antibiotic-sensitive Serratia marcescens infections complicating cardiopulmonary operations: contaminated disinfectant as a reservoir. Lancetii:1289-1292.
Elliott, B., and P. Masters.1977. Pseudomonas contamination of antiseptic/disinfectant solutions. Med. J. Aust.1:155-156.
Fox, J. G., C. M. Beaucage, C. A. Folta, and G. W. Thornton.1981. Nosocomial transmission of Serratia marcescens in a veterinary hospital due to contamination by benzalkonium chloride. J. Clin. Microbiol.14:157-160.
Frank, M. J., and W. Schaffner.1976. Contaminated aqueous benzalkonium chloride: an unnecessary hospital infection hazard. JAMA236:2418-2419.
Garner, J. S.1996. Guideline for isolation precautions in hospitals. Infect. Control Hosp. Epidemiol.17:53-80.
Gaynes, R., C. Richards, J. Edwards, T. G. Emori, T. Horan, J. Alonso-Echanove, S. Fridkin, R. Lawton, G. Peavy, and J. Tolson.2001. Feeding back surveillance data to prevent hospital-acquired infections. Emerg. Infect. Dis.7:295-298.
Georgia Division of Public Health.1990. Abscesses in an allergy practice due to Mycobacterium chelonae. Georgia Epidemiol. Rep.6:2.
Gerba, C. P., and P. Rusin.2001. Relationship between the use of antiseptics and disinfectants and the development of antimicrobial resistance, p. 187-194. In W. A. Rutala (ed.), Proceedings of the Conference on Disinfection, Antisepsis and Sterilization: practices and challenges for the new millennium. Association for Professionals in Infection Control and Epidemiology, Washington, DC.
Guinness, M., and J. Levey.1976. Contamination of aqueous dilutions of Resiguard disinfectant with Pseudomonas. Med. J. Aust.2:392.
Hamill, R. J., E. D. Houston, P. R. Georghiou, C. E. Wright, M. A. Koza, R. M. Cadle, P. A. Goepfert, D. A. Lewis, G. J. Zenon, and J. E. Clarridge.1995. An outbreak of Burkholderia cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann. Intern. Med.122:762-766.
Hardy, P. C., G. M. Elderer, and J. M. Matsen.1970. Contamination of commercially packaged urinary catheter kits with Pseudomonas EO-1. N. Engl. J. Med.282:33-35.
Horan, T. C., and R. Gaynes.2004. Surveillance of nosocomial infections, p. 1659-1702. In C. G. Mayhall (ed.), Hospital epidemiology and infection control. Lippincott Williams & Wilkins, Philadelphia, PA.
Hsueh, P.-R., L.-J. Teng, P.-C. Yang, H.-L. Pan, S.-W. Ho, and K.-T. Luh.1999. Nosocomial pseudoepidemic caused by Bacillus cereus traced to contaminated ethyl alcohol from a liquor factory. J. Clin. Microbiol.37:2280-2284.
Hugonnet, S., T. V. Perneger, and D. Pittet.2002. Alcohol-based handrub improves compliance with hand hygiene in intensive care units. Arch. Intern. Med.162:1037-1043.
Jarvis, W. R.1991. Nosocomial outbreaks: the Centers for Disease Control's Hospital Infections Program Experience, 1980-1990. Am. J. Med.91(Suppl 3B):101S-106S.
Jones, R. D.1999. Bacterial resistance and topical antimicrobial wash products. Am. J. Infect. Control27:351-363.
Kahan, A., A. Philippon, G. Paul, S. Weber, C. Richard, G. Hazebroucg, and M. Degeorges.1983. Nosocomial infections by chlorhexidine solution contaminated with Pseudomonas pickettii (biovar VA-1). J. Infect.7:256-263.
Kaslow, R. A., D. C. Mackel, and G. F. Mallison.1976. Nosocomial pseudobacteremia: positive blood cultures due to contaminated benzalkonium chloride. JAMA236:2407-2409.
Koo, D., B. Bouvier, M. Wesley, P. Courtright, and A. Reingold.1980. Epidemic keratoconjunctivitis in a university medical center ophthalmology clinic; need for re-evaluation of the design and disinfection of instruments. Infect. Control Hosp. Epidemiol.10:547-552.
Kressel, A. B., and F. Kidd.2001. Pseudo-outbreak of Mycobacterium chelonae and Methylobacterium mesophilicum caused by contamination of an automated endoscope washer. Infect. Control Hosp. Epidemiol.22:414-418.
Laskowski, L. F., J. J. Marr, J. F. Spernoga, N. J. Frank, H. B. Barner, G. Kaiser, and D. H. Tyras.1977. Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures. N. Engl. J. Med.297:101-102.
Lee, J. C., and P. J. Fialkow.1961. Benzalkonium chloride—source of hospital infection with gram-negative bacteria. JAMA177:708-710.
Lehours, P., A. M. Rogues, A. Occhialini, H. Boulestreau, J. P. Gachie, and F. Megraud.2002. Investigation of an outbreak of Alcaligenes xylosoxydans subspecies xylosoxydans by random polymorphic DNA analysis. Eur. J. Clin. Microbiol. Infect. Dis.21:108-113.
Malizia, M. F., E. J. Gangarosa, and A. F. Goley.1960. Benzalkonium chloride as a source of infection. N. Engl. J. Med.263:800-802.
Maroye, P., H. P. Doermann, A. M. Rogues, J. P. Gachie, and F. Megraud.2000. Investigation of an outbreak of Ralsontia pickettii in a paediatric hospital by RAPD. J. Hosp. Infect.44:267-272.
Marrie, T. J., and J. W. Costerton.1981. Prolonged survival of Serratia marcescens in chlorhexidine. Appl. Environ. Microbiol.42:1093-1102.
McAllister, T. A., C. E. Lucas, H. Mocan, R. H. Liddell, B. E. Gibson, I. M. Hann, and D. J. Platt.1989. Serratia marcescens outbreak in a paediatric hospital oncology unit traced to contaminated chlorhexidine. Scot. Med. J.34:525-528.
McDonnell, G., and A. D. Russell.1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev.12:147-179.
McNaughton, M., N. Mazinke, and E. Thomas.1995. Newborn conjunctivitis associated with 0.5% antiseptic intrinsically contaminated with Serratia marcescens. Can. J. Infect. Control10:7-8.
Mitchell, R. G., and A. C. Hayward.1966. Postoperative urinary-tract infections caused by contaminated irrigating fluid. Lanceti:793-795.
Morris, S., M. Gibbs, D. Hansman, N. Smyth, and D. Cosh.1976. Contamination of aqueous dilutions of Resiguard disinfectant with Pseudomonas. Med. J. Aust.2:110-111.
Nakashima, A. K., M. A. McCarthy, W. J. Martone, and R. L. Anderson.1987. Epidemic septic arthritis caused by Serratia marcescens and associated with benzalkonium chloride antiseptic. J. Clin. Microbiol.25:1014-1018.
Nasser, R. M., A. C. Rahi, M. F. Haddad, Z. Daoud, N. Irani-Hakime, and W. Almawi.2004. Outbreak of Burkholderia cepacia bacteremia traced to contaminated hospital water used for dilution of an alcohol skin antiseptic. Infect. Control Hosp. Epidemiol.25:231-239.
Newman, K. A., J. H. Tenney, H. A. Oken, M. R. Moody, R. Wharton, and S. C. Schimpff.1984. Persistent isolation of an unusual Pseudomonas species from a phenolic disinfectant system. Infect. Control5:219-222.
Olson, R. K., R. E. Voorhees, H. E. Eitzen, H. Rolka, and C. M. Sewell.1999. Cluster of postinjection abscesses related to corticosteroid injections and use of benzalkonium chloride. West. J. Med.170:143-147.
O'Rourke, E., D. Runyan, J. O'Leary, and J. Stern.2003. Contaminated iodophor in the operating room. Am. J. Infect. Control31:255-256.
Panlilio, A. L., C. M. Beck-Sague, J. D. Siegel, R. L. Anderson, S. Y. Yetts, N. C. Clark, P. N. Duer, K. A. Thomassen, R. W. Vess, and B. C. Hill.1992. Infections and pseudoinfections due to povidone-iodine solution contaminated with Pseudomonas cepacia. Clin. Infect. Dis.14:1078-1083.
Parrott, P. L., P. M. Terry, E. N. Whitworth, L. W. Frawley, R. S. Coble, I. K. Wachsmuth, and J. E. McGowan.1982. Pseudomonas aeruginosa peritonitis associated with contaminated poloxamer-iodine solution. Lancetii:683-685.
Pittet, D.2001. Compliance with hand disinfection and its impact on hospital-acquired infections. J. Hosp. Infect.48(Suppl A):S40-S46.
Plotkin, S. A., and R. Austrian.1958. Bacteremia caused by Pseudomonas sp. following the use of materials stored in solutions of a cationic surface-active agent. Am. J. Med. Sci.235:621-627.
Poole, K.2002. Mechanisms of bacterial biocide and antibiotic resistance. J. Appl. Microbiol.92(Suppl.):55S-64S.
Poty, F., C. Denis, and H. Baufine-Ducrocq.1987. Nosocomial Pseudomonas pickettii infection. Danger of the use of ion-exchange resins. Presse Med.20:1185-1187.
Reiss, I., A. Borkhardt, R. Fussle, A. Sziegoleit, and L. Gortner.2000. Disinfectant contaminated with Klebsiella oxytoca as a source of sepsis in babies. Lancet356:310.
Rotter, M. L.2001. Arguments for alcoholic hand disinfection. J. Hosp. Infect.48(Suppl A):S4-S8.
Russell, A. D., M. T. Suller, and J. Y. Maillard.1999. Do antiseptics and disinfectants select for antibiotic resistance? J. Med. Microbiol.48:613-615.
Russell, A. D.2004. Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. J. Hosp. Infect.57:97-104.
Russell, A. D.1999. Bacterial resistance to disinfectants: present knowledge and future problems. J. Hosp. Infect.43(Suppl):S57-S68.
Russell, A. D.2003. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect. Dis.3:794-803.
Russell, A. D.2000. Do biocides select for antibiotic resistance? J. Pharm. Pharmacol.52:227-233.
Russell, A. D.2001. Mechanisms of bacterial insusceptibility to biocides. Am. J. Infect. Control29:259-261.
Rutala, W. A., and E. C. Cole.1984. Antiseptics and disinfectants-safe and effective? Infect. Control5:215-218.
Rutala, W. A., D. J. Weber, and the Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in health-care facilities. Morb. Mortal. Wkly. Rep., in press.
Rutala, W. A., and D. J. Weber.2007. How to assess risk of disease transmission to patients when there is a failure to follow recommended disinfection and sterilization guidelines. Infect. Control Hosp. Epidemiol.28:146-155.
Rutala, W. A., and D. J. Weber.2004. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin. Infect. Dis.39:702-709.
Sanford, J. P.1970. Disinfectants that don't. Ann. Intern. Med.72:282-283.
Sauer, K., A. H. Rickard, and D. G. Davies.2007. Biofilms and biocomplexity. Microbe2:347-353.
Sautter, R. L., L. H. Mattman, and R. C. Legaspi.1984. Serratia marcescens meningitis associated with a contaminated benzalkonium chloride solution. Infect. Control5:223-225.
Sehulster, L. M., and R. Y. W. Chinn.2004. Guidelines for environmental infection control in health-care facilities. Recommendations from CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). American Society for Healthcare Engineering/American Hospital Association, Chicago IL.
Shickman, M. D., L. B. Guze, and M. L. Pearce.1959. Bacteremia following cardiac catheterization: report of a case and studies on the source. N. Engl. J. Med.260:1164-1166.
Siegel, J. D., E. Rhinehart, M. Jackson, L. Chiarello, and Healthcare Infection Control Practices Advisory Committee. December 2006, accession date. Management of multidrug-resistant organisms in healthcare settings, 2006. Centers for Disease Control and Prevention, Atlanta, GA.
Simmons, N. A., and D. A. Gardner.1969. Bacterial contamination of a phenolic disinfectant. Br. Med. J.2:668-669.
Sobel, J. D., N. Hashman, G. Reinherz, and D. Merzbach.1982. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am. J. Med.73:183-186.
Speller, D. C. E., M. E. Stephens, and A. C. Viant.1971. Hospital infection by Pseudomonas cepacia. Lanceti:798-799.
Tena, D., R. Carranza, J. R. Barberá, S. Valdezate, J. M. Garrancho, M. Arranz, and J. A. Sáez-Nieto.2005. Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit. Eur. J. Clin. Microbiol. Infect. Dis.24:727-732.
Tiwari, T. S., B. Ray, K. C. Jost, Jr., M. K. Rathod, Y. Zhang, B. A. Brown-Elliott, K. Hendricks, R. J. Wallace, Jr.2003. Forty years of disinfectant failure: outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium choride. Clin. Infect. Dis.36:954-962.
Tyras, D. H., G. C. Kaiser, H. B. Barner, L. F. Laskowski, and J. J. Marr.1978. Atypical mycobacteria and the xenograft valve. J. Thoracic Cardiovasc. Surg.75:331-337.
Vanholder, R., E. Vanhaecke, and S. Ringoir.1992. Pseudomonas septicemica due to deficient disinfectant mixing during reuse. Int. J. Artificial Organs15:19-24.
Verschraegen, G., G. Claeys, G. Meeus, and M. Delanghe.1985. Pseudomonas pickettii as a cause of pseudobacteremia. J. Clin. Microbiol.21:278-279.
Vigeant, P., V. G. Loo, C. Bertrand, C. Dixon, R. Hollis, M. A. Pfaller, A. P. McLean, D. J. Briedis, T. M. Perl, and H. G. Robson.1998. An outbreak of Serratia marcescens infections related to contaminated chlorhexidine. Infect. Control Hosp. Epidemiol.19:791-794.
Vu-Thien, H., J. C. Darbord, D. Moissenet, C. Dulot, J. B. Dufourcq, P. Marsol, and A. Garbarg-Chenon.1998. Investigation of an outbreak of wound infections due to Alcaligenes xylosoxidans transmitted by chlorhexidine in a burns unit. Eur. J. Clin. Microbiol. Infect. Dis.17:724-726.
Weber, D. J., and W. A. Rutala.2006. Use of germicides in the home and healthcare settings: is there a relationship between germicide use and antibiotic resistance? Infect. Control Hosp. Epidemiol.27:1107-1119.
Wishart, M. M., and T. V. Riley.1976. Infection with Pseudomonas maltophilia hospital outbreak due to contaminated disinfectant. Med. J. Aust.2:710-712.

Information & Contributors


Published In

Antimicrobial Agents and Chemotherapy cover image
Antimicrobial Agents and Chemotherapy
Volume 51Number 12December 2007
Pages: 4217 - 4224
PubMed: 17908945


Published online: 17 December 2020


Request permissions for this article.



David J. Weber [email protected]
Department of Hospital Epidemiology, University of North Carolina Health Care System, Chapel Hill, North Carolina
Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina
William A. Rutala
Department of Hospital Epidemiology, University of North Carolina Health Care System, Chapel Hill, North Carolina
Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina
Emily E. Sickbert-Bennett
Department of Hospital Epidemiology, University of North Carolina Health Care System, Chapel Hill, North Carolina

Metrics & Citations



If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

View Options

View options


Open ePub

Full Text

Open Full Text


Download PDF

Get Access

Buy Article
Antimicrobial Agents and Chemotherapy Vol.51 • Issue 12 • ASM Journals Pay Per View, PPV 25
Buy Article
Antimicrobial Agents and Chemotherapy Vol.51 • Issue 12 • ASM Journals Pay Per View, PPV 25
Journal Subscription
Antimicrobial Agents and Chemotherapy
ASM members can purchase subscriptions to journals.
Join or renew

Figures and Media






Share the article link

Share with email

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy